Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

3.02
-0.0300-0.98%
Pre-market: 3.110.0900+2.98%09:21 EDT
Volume:149.95K
Turnover:450.50K
Market Cap:4.97M
PE:-0.26
High:3.14
Open:2.92
Low:2.86
Close:3.05
Loading ...
May 05, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Major Issues Report

8-K - Current report
Jan 31, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 27, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Major Issues Report

8-K - Current report
Dec 27, 2021

Major Issues Report

8-K - Current report
Nov 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 29, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 25, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 12, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 07, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 27, 2021

Major Issues Report

8-K - Current report
Sep 22, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 17, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]